BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rabi FA, Al Zoubi MS, Kasasbeh GA, Salameh DM, Al-Nasser AD. SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far. Pathogens. 2020;9. [PMID: 32245083 DOI: 10.3390/pathogens9030231] [Cited by in Crossref: 260] [Cited by in F6Publishing: 209] [Article Influence: 130.0] [Reference Citation Analysis]
Number Citing Articles
1 Jackson-Thompson BM, Goguet E, Laing ED, Olsen CH, Pollett S, Hollis-Perry KM, Maiolatesi SE, Illinik L, Ramsey KF, Reyes AE, Alcorta Y, Wong MA, Davies J, Ortega O, Parmelee E, Lindrose AR, Moser M, Graydon E, Letizia AG, Duplessis CA, Ganesan A, Pratt KP, Malloy AM, Scott DW, Anderson SK, Snow AL, Dalgard CL, Powers JH 3rd, Tribble D, Burgess TH, Broder CC, Mitre E. Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers. BMC Infect Dis 2021;21:544. [PMID: 34107889 DOI: 10.1186/s12879-021-06233-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Jacob G, Aharon A, Brenner B. COVID-19-Associated Hyper-Fibrinolysis: Mechanism and Implementations. Front Physiol 2020;11:596057. [PMID: 33391014 DOI: 10.3389/fphys.2020.596057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Solnier J, Fladerer JP. Flavonoids: A complementary approach to conventional therapy of COVID-19? Phytochem Rev 2020;:1-23. [PMID: 32982616 DOI: 10.1007/s11101-020-09720-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
4 Saha RP, Sharma AR, Singh MK, Samanta S, Bhakta S, Mandal S, Bhattacharya M, Lee SS, Chakraborty C. Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19. Front Pharmacol. 2020;11:1258. [PMID: 32973505 DOI: 10.3389/fphar.2020.01258] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 20.5] [Reference Citation Analysis]
5 Awogbindin IO, Ben-Azu B, Olusola BA, Akinluyi ET, Adeniyi PA, Di Paolo T, Tremblay MÈ. Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism and Possible Relevance to Parkinson's Disease. Front Cell Neurosci 2021;15:670298. [PMID: 34211370 DOI: 10.3389/fncel.2021.670298] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Shang Z, Chan SY, Liu WJ, Li P, Huang W. Recent Insights into Emerging Coronavirus: SARS-CoV-2. ACS Infect Dis 2021;7:1369-88. [PMID: 33296169 DOI: 10.1021/acsinfecdis.0c00646] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
7 Ayala-ramírez P, González M, Escudero C, Quintero-arciniegas L, Giachini FR, Alves de Freitas R, Damiano AE, García-robles R. Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Pregnancy. A Non-systematic Review of Clinical Presentation, Potential Effects of Physiological Adaptations in Pregnancy, and Placental Vascular Alterations. Front Physiol 2022;13:785274. [DOI: 10.3389/fphys.2022.785274] [Reference Citation Analysis]
8 Beeckmans S, Van Driessche E. Scrutinizing Coronaviruses Using Publicly Available Bioinformatic Tools: The Viral Structural Proteins as a Case Study. Front Mol Biosci 2021;8:671923. [PMID: 34109214 DOI: 10.3389/fmolb.2021.671923] [Reference Citation Analysis]
9 Ratre YK, Kahar N, Bhaskar LVKS, Bhattacharya A, Verma HK. Molecular mechanism, diagnosis, and potential treatment for novel coronavirus (COVID-19): a current literature review and perspective. 3 Biotech 2021;11:94. [PMID: 33520580 DOI: 10.1007/s13205-021-02657-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
10 Donati Zeppa S, Agostini D, Piccoli G, Stocchi V, Sestili P. Gut Microbiota Status in COVID-19: An Unrecognized Player? Front Cell Infect Microbiol. 2020;10:576551. [PMID: 33324572 DOI: 10.3389/fcimb.2020.576551] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
11 Wong NA, Saier MH Jr. The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis. Int J Mol Sci 2021;22:1308. [PMID: 33525632 DOI: 10.3390/ijms22031308] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
12 Boix-besora A, Lorenzo E, Lavado-garcía J, Gòdia F, Cervera L. Optimization, Production, Purification and Characterization of HIV-1 GAG-Based Virus-like Particles Functionalized with SARS-CoV-2. Vaccines 2022;10:250. [DOI: 10.3390/vaccines10020250] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Moura RR, Agrelli A, Santos-Silva CA, Silva N, Assunção BR, Brandão L, Benko-Iseppon AM, Crovella S. Immunoinformatic approach to assess SARS-CoV-2 protein S epitopes recognised by the most frequent MHC-I alleles in the Brazilian population. J Clin Pathol 2021;74:528-32. [PMID: 32759312 DOI: 10.1136/jclinpath-2020-206946] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
14 Arita R, Ono R, Saito N, Takayama S, Namiki T, Ito T, Ishii T. Kakkonto, shosaikoto, Platycodon grandiflorum root, and gypsum (a Japanese original combination drug known as saikatsugekito): Pharmacological review of its activity against viral infections and respiratory inflammatory conditions and a discussion of its applications to COVID ‐19. Traditional & Kampo Medicine 2020;7:115-27. [DOI: 10.1002/tkm2.1258] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
15 Cardenas MC, Bustos SS, Enninga EAL, Mofenson L, Chakraborty R. Characterising and managing paediatric SARSCoV-2 infection: Learning about the virus in a global classroom. Acta Paediatr 2021;110:409-22. [PMID: 33175403 DOI: 10.1111/apa.15662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Bushra KF, Ahamed MA, Ahmad M. Automated detection of COVID-19 from X-ray images using CNN and Android mobile. Res Biomed Eng 2021;37:545-52. [DOI: 10.1007/s42600-021-00163-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
17 Kilani MM, Odeh MM, Shalabi M, Al Qassieh R, Al-tamimi M. Clinical and laboratory characteristics of SARS-CoV2-infected paediatric patients in Jordan: serial RT-PCR testing until discharge. Paediatrics and International Child Health 2021;41:83-92. [DOI: 10.1080/20469047.2020.1804733] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Dabanch J. EMERGENCIA DE SARS-COV-2. ASPECTOS BÁSICOS SOBRE SU ORIGEN, EPIDEMIOLOGÍA, ESTRUCTURA Y PATOGENIA PARA CLÍNICOS. Revista Médica Clínica Las Condes 2021;32:14-9. [DOI: 10.1016/j.rmclc.2020.12.003] [Reference Citation Analysis]
19 Chauhan N, Soni S, Jain U. Optimizing testing regimes for the detection of COVID-19 in children and older adults. Expert Rev Mol Diagn 2021;:1-18. [PMID: 34324823 DOI: 10.1080/14737159.2021.1962708] [Reference Citation Analysis]
20 Regasa T, Zemedkun A, Neme D, Aweke Z, Tadese M, Getachew H, Alemu B, Hailu S. The impact of novel coronavirus disease (COVID-19) on emergency and essential surgical care in Gedeo and Sidama zone hospitals: An institutional-based multicenter cross-sectional study. Annals of Medicine and Surgery 2022;77:103656. [DOI: 10.1016/j.amsu.2022.103656] [Reference Citation Analysis]
21 Sherren PB, Ostermann M, Agarwal S, Meadows CIS, Ioannou N, Camporota L. COVID-19-related organ dysfunction and management strategies on the intensive care unit: a narrative review. Br J Anaesth 2020;125:912-25. [PMID: 32988604 DOI: 10.1016/j.bja.2020.08.050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
22 Husaini AM, Jan KN, Wani GA. Saffron: A potential drug-supplement for severe acute respiratory syndrome coronavirus (COVID) management. Heliyon 2021;7:e07068. [PMID: 34007917 DOI: 10.1016/j.heliyon.2021.e07068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Turrubiates-Hernández FJ, Sánchez-Zuno GA, González-Estevez G, Hernández-Bello J, Macedo-Ojeda G, Muñoz-Valle JF. Potential immunomodulatory effects of vitamin D in the prevention of severe coronavirus disease 2019: An ally for Latin America (Review). Int J Mol Med 2021;47:32. [PMID: 33537824 DOI: 10.3892/ijmm.2021.4865] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
24 Roostaei Firozabad A, Meybodi ZA, Mousavinasab SR, Sahebnasagh A, Jelodar MG, Karimzadeh I, Habtemariam S, Saghafi F. Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial. BMC Infect Dis 2021;21:297. [PMID: 33761870 DOI: 10.1186/s12879-021-05983-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Segrelles-Calvo G, de S Araújo GR, Frases S. Systemic mycoses: a potential alert for complications in COVID-19 patients. Future Microbiol 2020;15:1405-13. [PMID: 33085538 DOI: 10.2217/fmb-2020-0156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
26 Morowitz JM, Pogson KB, Roque DA, Church FC. Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson’s Disease: A Narrative Review. Brain Sciences 2022;12:536. [DOI: 10.3390/brainsci12050536] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Loey M, Smarandache F, M. Khalifa NE. Within the Lack of Chest COVID-19 X-ray Dataset: A Novel Detection Model Based on GAN and Deep Transfer Learning. Symmetry 2020;12:651. [DOI: 10.3390/sym12040651] [Cited by in Crossref: 123] [Cited by in F6Publishing: 5] [Article Influence: 61.5] [Reference Citation Analysis]
28 Bchetnia M, Girard C, Duchaine C, Laprise C. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status. J Infect Public Health.  2020. [PMID: 32778421 DOI: 10.1016/j.jiph.2020.07.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 17.0] [Reference Citation Analysis]
29 Benarba B, Pandiella A. Medicinal Plants as Sources of Active Molecules Against COVID-19. Front Pharmacol 2020;11:1189. [PMID: 32848790 DOI: 10.3389/fphar.2020.01189] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 18.0] [Reference Citation Analysis]
30 Christensen B, Favaloro EJ, Lippi G, Van Cott EM. Hematology Laboratory Abnormalities in Patients with Coronavirus Disease 2019 (COVID-19). Semin Thromb Hemost 2020;46:845-9. [PMID: 32877961 DOI: 10.1055/s-0040-1715458] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
31 Swelum AA, Shafi ME, Albaqami NM, El-Saadony MT, Elsify A, Abdo M, Taha AE, Abdel-Moneim AE, Al-Gabri NA, Almaiman AA, Saleh Al-Wajeeh A, Tufarelli V, Staffa VN, Abd El-Hack ME. COVID-19 in Human, Animal, and Environment: A Review. Front Vet Sci 2020;7:578. [PMID: 33102545 DOI: 10.3389/fvets.2020.00578] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
32 Belete TM. A review on Promising vaccine development progress for COVID-19 disease. Vacunas 2020;21:121-8. [PMID: 32837460 DOI: 10.1016/j.vacun.2020.05.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
33 Ouassou H, Kharchoufa L, Bouhrim M, Daoudi NE, Imtara H, Bencheikh N, ELbouzidi A, Bnouham M. The Pathogenesis of Coronavirus Disease 2019 (COVID-19): Evaluation and Prevention. J Immunol Res 2020;2020:1357983. [PMID: 32671115 DOI: 10.1155/2020/1357983] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 12.5] [Reference Citation Analysis]
34 Siriwattananon K, Manopwisedjaroen S, Shanmugaraj B, Rattanapisit K, Phumiamorn S, Sapsutthipas S, Trisiriwanich S, Prompetchara E, Ketloy C, Buranapraditkun S, Wijagkanalan W, Tharakhet K, Kaewpang P, Leetanasaksakul K, Kemthong T, Suttisan N, Malaivijitnond S, Ruxrungtham K, Thitithanyanont A, Phoolcharoen W. Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates. Front Plant Sci 2021;12:682953. [PMID: 34054909 DOI: 10.3389/fpls.2021.682953] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
35 Alhalaili B, Popescu IN, Kamoun O, Alzubi F, Alawadhia S, Vidu R. Nanobiosensors for the Detection of Novel Coronavirus 2019-nCoV and Other Pandemic/Epidemic Respiratory Viruses: A Review. Sensors (Basel) 2020;20:E6591. [PMID: 33218097 DOI: 10.3390/s20226591] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
36 Yang J, Wu K, Ding A, Li L, Lu H, Zhu W, Xie K, Yao Z, Fang S. Clinical characteristics, treatment, and prognosis of 74 2019 novel coronavirus disease patients in Hefei: A single-center retrospective study. Medicine (Baltimore) 2021;100:e25645. [PMID: 34032692 DOI: 10.1097/MD.0000000000025645] [Reference Citation Analysis]
37 Hussain A, Yang H, Zhang M, Liu Q, Alotaibi G, Irfan M, He H, Chang J, Liang XJ, Weng Y, Huang Y. mRNA vaccines for COVID-19 and diverse diseases. J Control Release 2022;345:314-33. [PMID: 35331783 DOI: 10.1016/j.jconrel.2022.03.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
38 Hosseini A, Hashemi V, Shomali N, Asghari F, Gharibi T, Akbari M, Gholizadeh S, Jafari A. Innate and adaptive immune responses against coronavirus. Biomed Pharmacother 2020;132:110859. [PMID: 33120236 DOI: 10.1016/j.biopha.2020.110859] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
39 Mamedov T, Yuksel D, Ilgın M, Gurbuzaslan I, Gulec B, Yetiskin H, Uygut MA, Islam Pavel ST, Ozdarendeli A, Mammadova G, Say D, Hasanova G. Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice. Viruses 2021;13:1595. [PMID: 34452461 DOI: 10.3390/v13081595] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Aweke Z, Jemal B, Mola S, Hussen R. Knowledge of COVID-19 and its prevention among residents of the Gedeo zone, South Ethiopia. Sources of information as a factor. Curr Med Res Opin 2020;36:1955-60. [PMID: 33044091 DOI: 10.1080/03007995.2020.1835854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
41 Moore KA, Bouchoucha SL, Buchwald P. A comparison of the public's use of PPE and strategies to avoid contagion during the COVID-19 pandemic in Australia and Germany. Nurs Health Sci 2021;23:708-14. [PMID: 34091992 DOI: 10.1111/nhs.12857] [Reference Citation Analysis]
42 Prabhu S, Vijayakumar S, Praseetha P. Cyanobacterial metabolites as novel drug candidates in corona viral therapies: A review. Chronic Diseases and Translational Medicine. [DOI: 10.1002/cdt3.11] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Golota AS, Kamilova TA, Shneider OV, Vologzhanin DA, Sherbak SG. Pathogenesis of the initial stages of severe COVID-19. Journal of Clinical Practice 2021;12:83-102. [DOI: 10.17816/clinpract71351] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Clifton VL, Flathers KM, Brigham TJ. COVID-19 - Background and Health Sciences Library Response during the First Months of the Pandemic. Med Ref Serv Q 2021;40:1-10. [PMID: 33625334 DOI: 10.1080/02763869.2021.1873611] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Fotsa-Mbogne DJ, Tchoumi SY, Kouakep-Tchaptchie Y, Kamla VC, Kamgang JC, Houpa-Danga DE, Bowong-Tsakou S, Bekolle D. Estimation and optimal control of the multiscale dynamics of Covid-19: a case study from Cameroon. Nonlinear Dyn 2021;:1-36. [PMID: 34697521 DOI: 10.1007/s11071-021-06920-3] [Reference Citation Analysis]
46 Jiang M, Kolehmainen P, Kakkola L, Maljanen S, Melén K, Smura T, Julkunen I, Österlund P. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells. Microbiol Spectr 2021;9:e0077421. [PMID: 34378952 DOI: 10.1128/Spectrum.00774-21] [Reference Citation Analysis]
47 Cleary SJ, Pitchford SC, Amison RT, Carrington R, Robaina Cabrera CL, Magnen M, Looney MR, Gray E, Page CP. Animal models of mechanisms of SARS-CoV-2 infection and COVID-19 pathology. Br J Pharmacol 2020;177:4851-65. [PMID: 32462701 DOI: 10.1111/bph.15143] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 29.0] [Reference Citation Analysis]
48 Valjarević A, Milić M, Valjarević D, Stanojević-ristić Z, Petrović L, Milanović M, Filipović D, Ristanović B, Basarin B, Lukić T. Modelling and mapping of the COVID-19 trajectory and pandemic paths at global scale: A geographer’s perspective. Open Geosciences 2020;12:1603-16. [DOI: 10.1515/geo-2020-0156] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
49 Nitulescu GM, Paunescu H, Moschos SA, Petrakis D, Nitulescu G, Ion GND, Spandidos DA, Nikolouzakis TK, Drakoulis N, Tsatsakis A. Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review). Int J Mol Med 2020;46:467-88. [PMID: 32468014 DOI: 10.3892/ijmm.2020.4608] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 23.0] [Reference Citation Analysis]
50 Dhiman Y, Patidar GK, Arora S. Covid‐19 pandemic‐ response to challenges by blood transfusion services in India: a review report. VOXS 2020;15:365-73. [DOI: 10.1111/voxs.12563] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Islam MM, Mahmud S, Muhammad LJ, Islam MR, Nooruddin S, Ayon SI. Wearable Technology to Assist the Patients Infected with Novel Coronavirus (COVID-19). SN Comput Sci 2020;1:320. [PMID: 33063058 DOI: 10.1007/s42979-020-00335-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
52 De Masi L, Argenio MA, Giordano D, Facchiano A. Molecular Aspects of Spike–ACE2 Interaction. Encyclopedia 2022;2:96-108. [DOI: 10.3390/encyclopedia2010007] [Reference Citation Analysis]
53 Ramesh M, Anand K, Shahbaaz M, Abdellattif MH. Current Perspectives in the Discovery of Newer Medications Against the Outbreak of COVID-19. Front Mol Biosci 2021;8:648232. [PMID: 34322517 DOI: 10.3389/fmolb.2021.648232] [Reference Citation Analysis]
54 Kumar S, Ahmadian A, Kumar R, Kumar D, Singh J, Baleanu D, Salimi M. An Efficient Numerical Method for Fractional SIR Epidemic Model of Infectious Disease by Using Bernstein Wavelets. Mathematics 2020;8:558. [DOI: 10.3390/math8040558] [Cited by in Crossref: 101] [Cited by in F6Publishing: 38] [Article Influence: 50.5] [Reference Citation Analysis]
55 Gasmi A, Tippairote T, Mujawdiya PK, Peana M, Menzel A, Dadar M, Gasmi Benahmed A, Bjørklund G. Micronutrients as immunomodulatory tools for COVID-19 management. Clin Immunol 2020;220:108545. [PMID: 32710937 DOI: 10.1016/j.clim.2020.108545] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
56 Chrysostomou AC, Hezka Rodosthenous J, Topcu C, Papa C, Aristokleous A, Stathi G, Christodoulou C, Eleftheriou C, Stylianou DC, Kostrikis LG. A Multiallelic Molecular Beacon-Based Real-Time RT-PCR Assay for the Detection of SARS-CoV-2. Life (Basel) 2021;11:1146. [PMID: 34833022 DOI: 10.3390/life11111146] [Reference Citation Analysis]
57 Kwofie SK, Broni E, Asiedu SO, Kwarko GB, Dankwa B, Enninful KS, Tiburu EK, Wilson MD. Cheminformatics-Based Identification of Potential Novel Anti-SARS-CoV-2 Natural Compounds of African Origin. Molecules 2021;26:E406. [PMID: 33466743 DOI: 10.3390/molecules26020406] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
58 Quarleri J, Delpino MV. SARS-CoV-2 interacts with renin-angiotensin system: impact on the central nervous system in elderly patients. Geroscience 2022. [PMID: 35157210 DOI: 10.1007/s11357-022-00528-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Ahmadi Badi S, Tarashi S, Fateh A, Rohani P, Masotti A, Siadat SD. From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis. Mediators Inflamm 2021;2021:6611222. [PMID: 33953641 DOI: 10.1155/2021/6611222] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Chen Y, Liu F, Lee LP. Quantitative and ultrasensitive in situ immunoassay technology for SARS-CoV-2 detection in saliva. Sci Adv 2022;8:eabn3481. [PMID: 35613342 DOI: 10.1126/sciadv.abn3481] [Reference Citation Analysis]
61 Syrbu SA, Kiselev AN, Lebedev MA, Gubarev YA, Yurina ES, Lebedeva NS. Interaction of 5-[4'-(N-Methyl-1,3-benzimidazol-2-yl)phenyl]-10,15,20-tri-(N-methyl-3'-pyridyl)porphyrin Triiodide with SARS-CoV-2 Spike Protein. Russ J Gen Chem 2022;:1-6. [PMID: 35756101 DOI: 10.1134/S1070363222060123] [Reference Citation Analysis]
62 Verdecia M, Kokai-Kun JF, Kibbey M, Acharya S, Venema J, Atouf F. COVID-19 vaccine platforms: Delivering on a promise? Hum Vaccin Immunother 2021;17:2873-93. [PMID: 34033528 DOI: 10.1080/21645515.2021.1911204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Yu J, Azzam EI, Jadhav AB, Wang Y. COVID-19: The Disease, the Immunological Challenges, the Treatment with Pharmaceuticals and Low-Dose Ionizing Radiation. Cells 2021;10:2212. [PMID: 34571861 DOI: 10.3390/cells10092212] [Reference Citation Analysis]
64 Kim DY, Shinde SK, Lone S, Palem RR, Ghodake GS. COVID-19 Pandemic: Public Health Risk Assessment and Risk Mitigation Strategies. J Pers Med 2021;11:1243. [PMID: 34945715 DOI: 10.3390/jpm11121243] [Reference Citation Analysis]
65 Paiva MHS, Guedes DRD, Docena C, Bezerra MF, Dezordi FZ, Machado LC, Krokovsky L, Helvecio E, da Silva AF, Vasconcelos LRS, Rezende AM, da Silva SJR, Sales KGDS, de Sá BSLF, da Cruz DL, Cavalcanti CE, Neto AM, da Silva CTA, Mendes RPG, da Silva MAL, Gräf T, Resende PC, Bello G, Barros MDS, do Nascimento WRC, Arcoverde RML, Bezerra LCA, Filho SPB, Ayres CFJ, Wallau GL. Multiple Introductions Followed by Ongoing Community Spread of SARS-CoV-2 at One of the Largest Metropolitan Areas of Northeast Brazil. Viruses 2020;12:E1414. [PMID: 33316947 DOI: 10.3390/v12121414] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
66 Kim HS. Do an Altered Gut Microbiota and an Associated Leaky Gut Affect COVID-19 Severity? mBio 2021;12:e03022-20. [PMID: 33436436 DOI: 10.1128/mBio.03022-20] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
67 Araya S, Wordofa M, Mamo MA, Tsegay YG, Hordofa A, Negesso AE, Fasil T, Berhanu B, Begashaw H, Atlaw A, Niguse T, Cheru M, Tamir Z. The Magnitude of Hematological Abnormalities Among COVID-19 Patients in Addis Ababa, Ethiopia. J Multidiscip Healthc 2021;14:545-54. [PMID: 33688198 DOI: 10.2147/JMDH.S295432] [Reference Citation Analysis]
68 Rabi FA, Al Zoubi MS, Al-Iede MM, Kasasbeh G, Badran EF. Coronaviruses in children: A review of potential mechanisms of childhood protection. Acta Paediatr 2021;110:765-72. [PMID: 33247469 DOI: 10.1111/apa.15691] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
69 Saulle I, Vicentini C, Clerici M, Biasin M. Antigen presentation in SARS-CoV-2 infection: the role of class I HLA and ERAP polymorphisms. Hum Immunol 2021;82:551-60. [PMID: 34116863 DOI: 10.1016/j.humimm.2021.05.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Pluskota-Karwatka D, Hoffmann M, Barciszewski J. Reducing SARS-CoV-2 Pathological Protein Activity with Small Molecules. J Pharm Anal 2021. [PMID: 33842018 DOI: 10.1016/j.jpha.2021.03.012] [Reference Citation Analysis]
71 Corrêa CR, Costa BGGD, Dezanetti T, Filipini RE, Nunes EA. Changes in eating habits, sleep, and physical activity during coronavirus disease (COVID-19) pandemic: A longitudinal study in young Brazilian adult males. Nutr Health 2022;:2601060221081653. [PMID: 35234065 DOI: 10.1177/02601060221081653] [Reference Citation Analysis]
72 Mann R, Perisetti A, Gajendran M, Gandhi Z, Umapathy C, Goyal H. Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks. Front Med (Lausanne). 2020;7:581521. [PMID: 33282890 DOI: 10.3389/fmed.2020.581521] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
73 Nagu P, Parashar A, Behl T, Mehta V. CNS implications of COVID-19: a comprehensive review. Rev Neurosci 2021;32:219-34. [PMID: 33550782 DOI: 10.1515/revneuro-2020-0070] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
74 Chand AA, Lal PP, Prasad KA, Mamun KA. Practice, benefits, and impact of personal protective equipment (PPE) during COVID-19 pandemic: Envisioning the UN sustainable development goals (SDGs) through the lens of clean water sanitation, life below water, and life on land in Fiji. Ann Med Surg (Lond) 2021;70:102763. [PMID: 34462651 DOI: 10.1016/j.amsu.2021.102763] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Elrashdy F, Redwan EM, Uversky VN. Intrinsic disorder perspective of an interplay between the renin-angiotensin-aldosterone system and SARS-CoV-2. Infect Genet Evol 2020;85:104510. [PMID: 32853823 DOI: 10.1016/j.meegid.2020.104510] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
76 Xu R, Shi M, Li J, Song P, Li N. Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System. Front Bioeng Biotechnol 2020;8:862. [PMID: 32850726 DOI: 10.3389/fbioe.2020.00862] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
77 Galindo-González J. Live animal markets: Identifying the origins of emerging infectious diseases. Curr Opin Environ Sci Health 2022;25:100310. [PMID: 34931177 DOI: 10.1016/j.coesh.2021.100310] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Bellini H, Cretaz E, Rigonatti LF, Conto CDR, Melzer-Ribeiro DL, Busatto-Filho G, Brunoni AR, Gallucci-Neto J. Electroconvulsive therapy practice during the COVID-19 pandemic. Clinics (Sao Paulo) 2020;75:e2056. [PMID: 32578828 DOI: 10.6061/clinics/2020/e2056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
79 Ahmadian E, Hosseiniyan Khatibi SM, Razi Soofiyani S, Abediazar S, Shoja MM, Ardalan M, Zununi Vahed S. Covid-19 and kidney injury: Pathophysiology and molecular mechanisms. Rev Med Virol 2021;31:e2176. [PMID: 33022818 DOI: 10.1002/rmv.2176] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
80 Escobedo RA, Kaushal D, Singh DK. Insights Into the Changing Landscape of Coronavirus Disease 2019. Front Cell Infect Microbiol 2021;11:761521. [PMID: 35083164 DOI: 10.3389/fcimb.2021.761521] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
81 Rahbar Saadat Y, Hosseiniyan Khatibi SM, Zununi Vahed S, Ardalan M. Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza. Front Mol Biosci 2021;8:725528. [PMID: 34527703 DOI: 10.3389/fmolb.2021.725528] [Reference Citation Analysis]
82 Al Zamane S, Nobel FA, Jebin RA, Amin MB, Somadder PD, Antora NJ, Hossain MI, Islam MJ, Ahmed K, Moni MA. Development of an in silico multi-epitope vaccine against SARS-COV-2 by précised immune-informatics approaches. Inform Med Unlocked 2021;27:100781. [PMID: 34746365 DOI: 10.1016/j.imu.2021.100781] [Reference Citation Analysis]
83 van Breemen RB, Muchiri RN, Bates TA, Weinstein JB, Leier HC, Farley S, Tafesse FG. Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants. J Nat Prod 2022. [PMID: 35007072 DOI: 10.1021/acs.jnatprod.1c00946] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
84 Chi G, Memar Montazerin S, Lee JJ, Kazmi SHA, Shojaei F, Fitzgerald C, Gibson CM. Effect of azithromycin and hydroxychloroquine in patients hospitalized with COVID-19: Network meta-analysis of randomized controlled trials. J Med Virol 2021. [PMID: 34370328 DOI: 10.1002/jmv.27259] [Reference Citation Analysis]
85 Kichloo A, Dettloff K, Aljadah M, Albosta M, Jamal S, Singh J, Wani F, Kumar A, Vallabhaneni S, Khan MZ. COVID-19 and Hypercoagulability: A Review. Clin Appl Thromb Hemost 2020;26:1076029620962853. [PMID: 33074732 DOI: 10.1177/1076029620962853] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
86 Biţă A, Scorei IR, Mogoantă L, Bejenaru C, Mogoşanu GD, Bejenaru LE. Natural and semisynthetic candidate molecules for COVID-19 prophylaxis and treatment. Rom J Morphol Embryol 2020;61:321-34. [PMID: 33544784 DOI: 10.47162/RJME.61.2.02] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Tsukagoshi H, Shinoda D, Saito M, Okayama K, Sada M, Kimura H, Saruki N. Relationships between Viral Load and the Clinical Course of COVID-19. Viruses 2021;13:304. [PMID: 33672005 DOI: 10.3390/v13020304] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
88 Kumari M, Kumar A. Can pharmaceutical drugs used to treat Covid-19 infection leads to human health risk? A hypothetical study to identify potential risk. Sci Total Environ 2021;778:146303. [PMID: 34030377 DOI: 10.1016/j.scitotenv.2021.146303] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
89 Sessa F, Bertozzi G, Cipolloni L, Baldari B, Cantatore S, D'Errico S, Di Mizio G, Asmundo A, Castorina S, Salerno M, Pomara C. Clinical-Forensic Autopsy Findings to Defeat COVID-19 Disease: A Literature Review. J Clin Med 2020;9:E2026. [PMID: 32605192 DOI: 10.3390/jcm9072026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
90 Combadière B, Adam L, Guillou N, Quentric P, Rosenbaum P, Dorgham K, Bonduelle O, Parizot C, Sauce D, Mayaux J, Luyt CE, Boissonnas A, Amoura Z, Pourcher V, Miyara M, Gorochov G, Guihot A, Combadière C. LOX-1-Expressing Immature Neutrophils Identify Critically-Ill COVID-19 Patients at Risk of Thrombotic Complications. Front Immunol 2021;12:752612. [PMID: 34616409 DOI: 10.3389/fimmu.2021.752612] [Reference Citation Analysis]
91 Keskinidou C, Vassiliou AG, Zacharis A, Jahaj E, Gallos P, Dimopoulou I, Orfanos SE, Kotanidou A. Endothelial, Immunothrombotic, and Inflammatory Biomarkers in the Risk of Mortality in Critically Ill COVID-19 Patients: The Role of Dexamethasone. Diagnostics (Basel) 2021;11:1249. [PMID: 34359331 DOI: 10.3390/diagnostics11071249] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
92 Holford P, Carr AC, Zawari M, Vizcaychipi MP. Vitamin C Intervention for Critical COVID-19: A Pragmatic Review of the Current Level of Evidence. Life (Basel) 2021;11:1166. [PMID: 34833042 DOI: 10.3390/life11111166] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
93 do Vale B, Lopes AP, Fontes MDC, Silvestre M, Cardoso L, Coelho AC. Bats, pangolins, minks and other animals - villains or victims of SARS-CoV-2? Vet Res Commun 2021;45:1-19. [PMID: 33464439 DOI: 10.1007/s11259-021-09787-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
94 Kohmer N, Westhaus S, Rühl C, Ciesek S, Rabenau HF. Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays. J Clin Virol 2020;129:104480. [PMID: 32505777 DOI: 10.1016/j.jcv.2020.104480] [Cited by in Crossref: 105] [Cited by in F6Publishing: 88] [Article Influence: 52.5] [Reference Citation Analysis]
95 Cihan P, Ozger ZB. A new approach for determining SARS-CoV-2 epitopes using machine learning-based in silico methods. Computational Biology and Chemistry 2022. [DOI: 10.1016/j.compbiolchem.2022.107688] [Reference Citation Analysis]
96 Bolevich SB, Litvitsky PF, Grachev SV, Vorobyev SI, Orlova AS, Fokina MA, Novikov AA, Bolevich SS, Mikhaleva AY, Morozova EM, Kartashova MK, Yavlieva KH, Gudanovich DV, Srejovic I, Jakovljevic V. Fundamental Basis of COVID-19 Pathogenesis. Serbian Journal of Experimental and Clinical Research 2020;21:93-111. [DOI: 10.2478/sjecr-2020-0029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
97 Kumar M, Gulati S, Ansari AH, Phutela R, Acharya S, Azhar M, Murthy J, Kathpalia P, Kanakan A, Maurya R, Vasudevan JS, S A, Pandey R, Maiti S, Chakraborty D. FnCas9-based CRISPR diagnostic for rapid and accurate detection of major SARS-CoV-2 variants on a paper strip. Elife 2021;10:e67130. [PMID: 34106048 DOI: 10.7554/eLife.67130] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
98 Sercy E, Duane TM, Lieser M, Madayag RM, Berg G, Banton KL, Hamilton D, Bar-Or D. Effect of the COVID-19 pandemic on health insurance coverage among trauma patients: a study of six level I trauma centers. Trauma Surg Acute Care Open 2021;6:e000640. [PMID: 33884306 DOI: 10.1136/tsaco-2020-000640] [Reference Citation Analysis]
99 Al-Tammemi AB. The Battle Against COVID-19 in Jordan: An Early Overview of the Jordanian Experience. Front Public Health 2020;8:188. [PMID: 32574291 DOI: 10.3389/fpubh.2020.00188] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 17.0] [Reference Citation Analysis]
100 Dömling A, Gao L. Chemistry and Biology of SARS-CoV-2. Chem 2020;6:1283-95. [PMID: 32529116 DOI: 10.1016/j.chempr.2020.04.023] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 19.0] [Reference Citation Analysis]
101 Roychoudhury S, Das A, Sengupta P, Dutta S, Roychoudhury S, Choudhury AP, Ahmed ABF, Bhattacharjee S, Slama P. Viral Pandemics of the Last Four Decades: Pathophysiology, Health Impacts and Perspectives. Int J Environ Res Public Health 2020;17:E9411. [PMID: 33333995 DOI: 10.3390/ijerph17249411] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
102 Dragun R, Veček NN, Marendić M, Pribisalić A, Đivić G, Cena H, Polašek O, Kolčić I. Have Lifestyle Habits and Psychological Well-Being Changed among Adolescents and Medical Students Due to COVID-19 Lockdown in Croatia? Nutrients 2020;13:E97. [PMID: 33396690 DOI: 10.3390/nu13010097] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
103 Volgenant CMC, Persoon IF, de Ruijter RAG, de Soet JJH. Infection control in dental health care during and after the SARS-CoV-2 outbreak. Oral Dis 2021;27 Suppl 3:674-83. [PMID: 32391651 DOI: 10.1111/odi.13408] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 13.5] [Reference Citation Analysis]
104 Fresán U, Guevara M, Trobajo-Sanmartín C, Burgui C, Ezpeleta C, Castilla J. Hypertension and Related Comorbidities as Potential Risk Factors for COVID-19 Hospitalization and Severity: A Prospective Population-Based Cohort Study. J Clin Med 2021;10:1194. [PMID: 33809217 DOI: 10.3390/jcm10061194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
105 Reyes-Bueno JA, García-Trujillo L, Urbaneja P, Ciano-Petersen NL, Postigo-Pozo MJ, Martínez-Tomás C, Serrano-Castro PJ. Miller-Fisher syndrome after SARS-CoV-2 infection. Eur J Neurol 2020;27:1759-61. [PMID: 32503084 DOI: 10.1111/ene.14383] [Cited by in Crossref: 61] [Cited by in F6Publishing: 43] [Article Influence: 30.5] [Reference Citation Analysis]
106 Giordano D, De Masi L, Argenio MA, Facchiano A. Structural Dissection of Viral Spike-Protein Binding of SARS-CoV-2 and SARS-CoV-1 to the Human Angiotensin-Converting Enzyme 2 (ACE2) as Cellular Receptor. Biomedicines 2021;9:1038. [PMID: 34440241 DOI: 10.3390/biomedicines9081038] [Reference Citation Analysis]
107 Narasimhulu CA, Singla DK. Mechanisms of COVID-19 Pathogenesis in Diabetes. Am J Physiol Heart Circ Physiol 2022. [PMID: 35776683 DOI: 10.1152/ajpheart.00204.2022] [Reference Citation Analysis]
108 Lopez-Castaneda S, García-Larragoiti N, Cano-Mendez A, Blancas-Ayala K, Damian-Vázquez G, Perez-Medina AI, Chora-Hernández LD, Arean-Martínez C, Viveros-Sandoval ME. Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection. Clin Appl Thromb Hemost 2021;27:1076029621999099. [PMID: 33835872 DOI: 10.1177/1076029621999099] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
109 Bustos-Arriagada E, Fuentealba-Urra S, Etchegaray-Armijo K, Quintana-Aguirre N, Castillo-Valenzuela O. Feeding Behaviour and Lifestyle of Children and Adolescents One Year after Lockdown by the COVID-19 Pandemic in Chile. Nutrients 2021;13:4138. [PMID: 34836396 DOI: 10.3390/nu13114138] [Reference Citation Analysis]
110 Nain Z, Rana HK, Liò P, Islam SMS, Summers MA, Moni MA. Pathogenetic profiling of COVID-19 and SARS-like viruses. Brief Bioinform 2021;22:1175-96. [PMID: 32778874 DOI: 10.1093/bib/bbaa173] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
111 Ahmad MF, Ali M, Alsayegh ARA, Ahmad S, Alam N, Wahab S, Ali MS, Athar MT. A current novel perspective approach for coronavirus disease-2019 pandemic outbreak. J Adv Pharm Technol Res 2021;12:311-20. [PMID: 34820303 DOI: 10.4103/japtr.JAPTR_159_21] [Reference Citation Analysis]
112 Yadav R, Hasan S, Mahato S, Celik I, Mary YS, Kumar A, Dhamija P, Sharma A, Choudhary N, Chaudhary PK, Kushwah AS, Chaudhary JK. Molecular docking, DFT analysis, and dynamics simulation of natural bioactive compounds targeting ACE2 and TMPRSS2 dual binding sites of spike protein of SARS CoV-2. J Mol Liq 2021;:116942. [PMID: 34305216 DOI: 10.1016/j.molliq.2021.116942] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
113 Jabłońska-trypuć A, Makuła M, Włodarczyk-makuła M, Wołejko E, Wydro U, Serra-majem L, Wiater J. Inanimate Surfaces as a Source of Hospital Infections Caused by Fungi, Bacteria and Viruses with Particular Emphasis on SARS-CoV-2. IJERPH 2022;19:8121. [DOI: 10.3390/ijerph19138121] [Reference Citation Analysis]
114 Gubarev YA, Lebedeva NS, Yurina ES, Syrbu SS, Kiselev AN, Lebedev MA. Possible therapeutic targets and promising drugs based on unsymmetrical hetaryl-substituted porphyrins to combat SARS-CoV-2. J Pharm Anal 2021. [PMID: 34377564 DOI: 10.1016/j.jpha.2021.08.003] [Reference Citation Analysis]
115 Rabiu Abubakar A, Ahmad R, Rowaiye AB, Rahman S, Iskandar K, Dutta S, Oli AN, Dhingra S, Tor MA, Etando A, Kumar S, Irfan M, Gowere M, Chowdhury K, Akter F, Jahan D, Schellack N, Haque M. Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm. Life 2022;12:478. [DOI: 10.3390/life12040478] [Reference Citation Analysis]
116 Matias-perez D, Hernandez-bautista E, Antonio Garcia-montalvo I. Oxidative Stress Derived from COVID-19 and Its Possible Association with the Development of Neurodegenerative Diseases. Arch Neurosci 2022;In Press. [DOI: 10.5812/ans.123302] [Reference Citation Analysis]
117 Selvaraj C, Panwar U, Dinesh DC, Boura E, Singh P, Dubey VK, Singh SK. Microsecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease. Front Chem 2020;8:595273. [PMID: 33585398 DOI: 10.3389/fchem.2020.595273] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
118 Kohmer N, Westhaus S, Rühl C, Ciesek S, Rabenau HF. Clinical performance of different SARS-CoV-2 IgG antibody tests. J Med Virol 2020;92:2243-7. [PMID: 32510168 DOI: 10.1002/jmv.26145] [Cited by in Crossref: 62] [Cited by in F6Publishing: 69] [Article Influence: 31.0] [Reference Citation Analysis]
119 Islam MM, Wang Y, Hu P. A Maximum Flow-Based Approach to Prioritize Drugs for Drug Repurposing of Chronic Diseases. Life (Basel) 2021;11:1115. [PMID: 34832991 DOI: 10.3390/life11111115] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Erickson MA, Rhea EM, Knopp RC, Banks WA. Interactions of SARS-CoV-2 with the Blood-Brain Barrier. Int J Mol Sci 2021;22:2681. [PMID: 33800954 DOI: 10.3390/ijms22052681] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
121 Halim FS, Parmin NA, Hashim U, Gopinath SCB, Dahalan FA, Zakaria II, Ang WC, Jaapar NF. MicroRNA of N-region from SARS-CoV-2: Potential sensing components for biosensor development. Biotechnol Appl Biochem 2021. [PMID: 34378814 DOI: 10.1002/bab.2239] [Reference Citation Analysis]
122 Ismail MI, Ragab HM, Bekhit AA, Ibrahim TM. Targeting multiple conformations of SARS-CoV2 Papain-Like Protease for drug repositioning: An in-silico study. Comput Biol Med 2021;131:104295. [PMID: 33662683 DOI: 10.1016/j.compbiomed.2021.104295] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
123 Lev-Ari S, Rolnik B, Volovitz I. Immune Responses to SARS-CoV2 Mirror Societal Responses to COVID-19: Identifying Factors Underlying a Successful Viral Response. Biology (Basel) 2021;10:485. [PMID: 34072585 DOI: 10.3390/biology10060485] [Reference Citation Analysis]
124 Wastnedge EAN, Reynolds RM, van Boeckel SR, Stock SJ, Denison FC, Maybin JA, Critchley HOD. Pregnancy and COVID-19. Physiol Rev 2021;101:303-18. [PMID: 32969772 DOI: 10.1152/physrev.00024.2020] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 26.5] [Reference Citation Analysis]
125 Mahmud-Al-Rafat A, Muzammal Haque Asim M, Taylor-Robinson AW, Majumder A, Muktadir A, Muktadir H, Karim M, Khan I, Mainul Ahasan M, Morsaline Billah M. A combinational approach to restore cytokine balance and to inhibit virus growth may promote patient recovery in severe COVID-19 cases. Cytokine 2020;136:155228. [PMID: 32822911 DOI: 10.1016/j.cyto.2020.155228] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
126 Gurung AB, Ali MA, Lee J, Farah MA, Al-Anazi KM. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 Mpro enzyme through in silico approach. Life Sci 2020;255:117831. [PMID: 32450166 DOI: 10.1016/j.lfs.2020.117831] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 25.5] [Reference Citation Analysis]
127 Rahmani R, Eivazi N, Paknejad M, Aminian M. A theoretical strategy for acceleration of human immune response against SARS-CoV-2: a fusion protein harboring virus-binding and pre-exposed antigen domains. Virusdisease 2021;:1-4. [PMID: 34277894 DOI: 10.1007/s13337-021-00704-4] [Reference Citation Analysis]
128 Abenavoli L, Cinaglia P, Lombardo G, Boffoli E, Scida M, Procopio AC, Larussa T, Boccuto L, Zanza C, Longhitano Y, Fagoonee S, Luzza F. Anxiety and Gastrointestinal Symptoms Related to COVID-19 during Italian Lockdown. J Clin Med 2021;10:1221. [PMID: 33809403 DOI: 10.3390/jcm10061221] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
129 Pagadala NS, Landi A, Maturu P, Tuszynski J. In silico identification of RBD subdomain of spike protein from Pro322-Thr581 for applications in vaccine development against SARS-CoV2. J Mol Struct 2021;1240:130534. [PMID: 33967342 DOI: 10.1016/j.molstruc.2021.130534] [Reference Citation Analysis]
130 Ramadan M, Hasan Z, Saleh T, Jaradat M, Al-Hazaimeh M, Bani Hani O, Al-Tammemi AB, Shorman E, Al-Mistarehi AH, Kheirallah K. Beyond knowledge: Evaluating the practices and precautionary measures towards COVID-19 amongst medical doctors in Jordan. Int J Clin Pract 2021;75:e14122. [PMID: 33650228 DOI: 10.1111/ijcp.14122] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
131 Alzaabi MM, Hamdy R, Ashmawy NS, Hamoda AM, Alkhayat F, Khademi NN, Al Joud SMA, El-Keblawy AA, Soliman SSM. Flavonoids are promising safe therapy against COVID-19. Phytochem Rev 2021;:1-22. [PMID: 34054380 DOI: 10.1007/s11101-021-09759-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
132 Azad GK. Identification of novel mutations in the methyltransferase complex (Nsp10-Nsp16) of SARS-CoV-2. Biochem Biophys Rep 2020;24:100833. [PMID: 33072893 DOI: 10.1016/j.bbrep.2020.100833] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
133 Sanyaolu A, Okorie C, Hosein Z, Patidar R, Desai P, Prakash S, Jaferi U, Mangat J, Marinkovic A. Global Pandemicity of COVID-19: Situation Report as of June 9, 2020. Infect Dis (Auckl) 2021;14:1178633721991260. [PMID: 33597811 DOI: 10.1177/1178633721991260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Ferreira G, Santander A, Savio F, Guirado M, Sobrevia L, Nicolson GL. SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases. Biochim Biophys Acta Mol Basis Dis 2021;1867:166264. [PMID: 34481867 DOI: 10.1016/j.bbadis.2021.166264] [Reference Citation Analysis]
135 Quiles JL, Rivas-García L, Varela-López A, Llopis J, Battino M, Sánchez-González C. Do nutrients and other bioactive molecules from foods have anything to say in the treatment against COVID-19? Environ Res 2020;191:110053. [PMID: 32835682 DOI: 10.1016/j.envres.2020.110053] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 12.0] [Reference Citation Analysis]
136 Silva TF, Tomiotto-Pellissier F, Sanfelice RA, Gonçalves MD, da Silva Bortoleti BT, Detoni MB, Rodrigues ACJ, Carloto ACM, Concato VM, Siqueira EDS, Costa IN, Pavanelli WR, Conchon-Costa I, Miranda-Sapla MM. A 21st Century Evil: Immunopathology and New Therapies of COVID-19. Front Immunol 2020;11:562264. [PMID: 33193331 DOI: 10.3389/fimmu.2020.562264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
137 Prakash P, Meena R, Stanley Abraham L, Sunkar S, Govindaraju K, Pully D, Samrot AV. Evidence-based traditional Siddha formulations for prophylaxis and management of respiratory symptoms in COVID-19 pandemic-a review. Biocatal Agric Biotechnol 2021;35:102056. [PMID: 34122672 DOI: 10.1016/j.bcab.2021.102056] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 BaHammam AS, Bindayna KM, Joji RM, Jahrami H, Faris MAE, Bragazzi NL. Outcomes of COVID-19 in the Eastern Mediterranean Region in the first 4 months of the pandemic. Saudi Med J 2020;41:907-15. [PMID: 32893272 DOI: 10.15537/smj.2020.9.25320] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
139 Sumirtanurdin R, Barliana MI. Coronavirus Disease 2019 Vaccine Development: An Overview. Viral Immunol 2021;34:134-44. [PMID: 32985963 DOI: 10.1089/vim.2020.0119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
140 Kumar P, Malik YS, Ganesh B, Rahangdale S, Saurabh S, Natesan S, Srivastava A, Sharun K, Yatoo MI, Tiwari R, Singh RK, Dhama K. CRISPR-Cas System: An Approach With Potentials for COVID-19 Diagnosis and Therapeutics. Front Cell Infect Microbiol 2020;10:576875. [PMID: 33251158 DOI: 10.3389/fcimb.2020.576875] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
141 Santos IA, Grosche VR, Bergamini FRG, Sabino-Silva R, Jardim ACG. Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment? Front Microbiol 2020;11:1818. [PMID: 32903349 DOI: 10.3389/fmicb.2020.01818] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
142 Borrego-Morell JA, Huertas EJ, Torrado N. On the effect of COVID-19 pandemic in the excess of human mortality. The case of Brazil and Spain. PLoS One 2021;16:e0255909. [PMID: 34473711 DOI: 10.1371/journal.pone.0255909] [Reference Citation Analysis]
143 Jannatdoust Z, Shamekhi S, Hanaee J, Soltani S, Garjani A. Persistence of SARS-Cov-2 on the Beauty Products, Their Containers’ Surfaces, and the Possibility of Secondary and Cross-Contamination. Pharm Sci 2020;26:S84-6. [DOI: 10.34172/ps.2020.68] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
144 Smail SW, Saeed M, Twana Alkasalias, Khudhur ZO, Younus DA, Rajab MF, Abdulahad WH, Hussain HI, Niaz K, Safdar M. Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review. Food Chem Toxicol 2021;150:112087. [PMID: 33640537 DOI: 10.1016/j.fct.2021.112087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 Kaur A, Chopra M, Bhushan M, Gupta S, Kumari P H, Sivagurunathan N, Shukla N, Rajagopal S, Bhalothia P, Sharma P, Naravula J, Suravajhala R, Gupta A, Abbasi BA, Goswami P, Singh H, Narang R, Polavarapu R, Medicherla KM, Valadi J, Kumar S A, Chaubey G, Singh KK, Bandapalli OR, Kavi Kishor PB, Suravajhala P. The Omic Insights on Unfolding Saga of COVID-19. Front Immunol 2021;12:724914. [PMID: 34745097 DOI: 10.3389/fimmu.2021.724914] [Reference Citation Analysis]
146 Asiedu SO, Kwofie SK, Broni E, Wilson MD. Computational Identification of Potential Anti-Inflammatory Natural Compounds Targeting the p38 Mitogen-Activated Protein Kinase (MAPK): Implications for COVID-19-Induced Cytokine Storm. Biomolecules 2021;11:653. [PMID: 33946644 DOI: 10.3390/biom11050653] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
147 Jungwirth-Weinberger A, Oezel L, Morgenstern R, Shue J, Hanreich C, Sama AA, Boettner F. D-Dimer Levels Are Not Elevated in SARS-CoV-2 IgG Positive Patients Undergoing Elective Orthopedic Surgery. J Clin Med 2021;10:3508. [PMID: 34441803 DOI: 10.3390/jcm10163508] [Reference Citation Analysis]
148 Yadav A, Ojha MD, Hariprasad P. Computational studies evidenced the potential of steroidal lactone to disrupt surface interaction of SARS-CoV-2 spike protein and hACE2. Comput Biol Med 2022;146:105598. [PMID: 35596971 DOI: 10.1016/j.compbiomed.2022.105598] [Reference Citation Analysis]
149 C L, Upadhyaya A, Neogi AG, Niranjan V. Identification of novel regulatory pathways across normal human bronchial epithelial cell lines (NHBEs) and peripheral blood mononuclear cell lines (PBMCs) in COVID-19 patients using transcriptome analysis. Inform Med Unlocked 2022;31:100979. [PMID: 35669390 DOI: 10.1016/j.imu.2022.100979] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Campos-Ferreira D, Visani V, Córdula C, Nascimento GA, Montenegro LML, Schindler HC, Cavalcanti IMF. COVID-19 challenges: From SARS-CoV-2 infection to effective point-of-care diagnosis by electrochemical biosensing platforms. Biochem Eng J 2021;176:108200. [PMID: 34522158 DOI: 10.1016/j.bej.2021.108200] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Sayan M, Sarigul Yildirim F, Sanlidag T, Uzun B, Uzun Ozsahin D, Ozsahin I. Capacity Evaluation of Diagnostic Tests For COVID-19 Using Multicriteria Decision-Making Techniques. Comput Math Methods Med 2020;2020:1560250. [PMID: 32802146 DOI: 10.1155/2020/1560250] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
152 Ceccarelli G, Marazzato M, Celani L, Lombardi F, Piccirilli A, Mancone M, Trinchieri V, Pugliese F, Mastroianni CM, d'Ettorre G. Oxygen Sparing Effect of Bacteriotherapy in COVID-19. Nutrients 2021;13:2898. [PMID: 34445055 DOI: 10.3390/nu13082898] [Reference Citation Analysis]
153 Çakıcı N, Avşar G, Çalışkan N. The Challenges of Nurses Who Care for COVID-19 Patients: A Qualitative Study. Holist Nurs Pract 2021;35:315-20. [PMID: 34647913 DOI: 10.1097/HNP.0000000000000480] [Reference Citation Analysis]
154 Witkowska D. Mass Spectrometry and Structural Biology Techniques in the Studies on the Coronavirus-Receptor Interaction. Molecules 2020;25:E4133. [PMID: 32927621 DOI: 10.3390/molecules25184133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Kapustova L, Petrovicova O, Banovcin P, Antosova M, Bobcakova A, Urbancikova I, Rennerova Z, Jesenak M. COVID-19 and the differences in physiological background between children and adults and their clinical consequences. Physiol Res 2021;70:S209-25. [PMID: 34913353 DOI: 10.33549/physiolres.934759] [Reference Citation Analysis]
156 Leao JC, Gusmao TPL, Zarzar AM, Leao Filho JC, Barkokebas Santos de Faria A, Morais Silva IH, Gueiros LAM, Robinson NA, Porter S, Carvalho AAT. Coronaviridae-Old friends, new enemy! Oral Dis 2020. [PMID: 32475006 DOI: 10.1111/odi.13447] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
157 Lei KC, Zhang XD. Conservation analysis of SARS-CoV-2 spike suggests complicated viral adaptation history from bat to human. Evol Med Public Health 2020;2020:290-303. [PMID: 33372198 DOI: 10.1093/emph/eoaa041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
158 Cao XJ, Fang KY, Zhou J, Li YP, Guo XG. The Diagnostic Accuracy of Xpert Xpress to SARS-CoV-2: a systematic review. J Virol Methods 2022;:114460. [PMID: 35032480 DOI: 10.1016/j.jviromet.2022.114460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
159 Pérez-rodríguez S, de la Caridad Rodríguez-gonzález M, Ochoa-azze R, Climent-ruiz Y, Alberto González-delgado C, Paredes-moreno B, Valenzuela-silva C, Rodríguez-noda L, Perez-nicado R, González-mugica R, Martínez-pérez M, Sánchez-ramírez B, Hernández-garcía T, Díaz-machado A, Tamayo-rodríguez M, Martín-trujillo A, Rubino-moreno J, Suárez-batista A, Dubed-echevarría M, Teresa Pérez-guevara M, Amoroto-roig M, Chappi-estévez Y, Bergado-báez G, Pi-estopiñán F, Chen G, Valdés-balbín Y, García-rivera D, Verez-bencomo V. A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.02.029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
160 Korath ADJ, Janda J, Untersmayr E, Sokolowska M, Feleszko W, Agache I, Adel Seida A, Hartmann K, Jensen-Jarolim E, Pali-Schöll I. One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-CoV-2. Allergy 2022;77:55-71. [PMID: 34180546 DOI: 10.1111/all.14991] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
161 Alrawashdeh HM, Al-Tammemi AB, Alzawahreh MK, Al-Tamimi A, Elkholy M, Al Sarireh F, Abusamak M, Elehamer NMK, Malkawi A, Al-Dolat W, Abu-Ismail L, Al-Far A, Ghoul I. Occupational burnout and job satisfaction among physicians in times of COVID-19 crisis: a convergent parallel mixed-method study. BMC Public Health 2021;21:811. [PMID: 33906619 DOI: 10.1186/s12889-021-10897-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
162 Hajure M, Dibaba B, Shemsu S, Desalegn D, Reshad M, Mohammedhussein M. Psychological Distress Among Health Care Workers in Health Facilities of Mettu Town During COVID-19 Outbreak, South West Ethiopia, 2020. Front Psychiatry 2021;12:574671. [PMID: 34248689 DOI: 10.3389/fpsyt.2021.574671] [Reference Citation Analysis]
163 Lee L, Liu F, Chen Y, Roma G. Quantitative and Ultrasensitive In-situ Immunoassay Technology for SARS-CoV-2 Detection in Saliva. Res Sq 2021:rs. [PMID: 33469572 DOI: 10.21203/rs.3.rs-138025/v1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
164 Kumar G, Kumar D, Singh NP. Therapeutic Approach Against 2019-nCoV by Inhibition of the ACE-2 receptor. Drug Res (Stuttg) 2020. [PMID: 33368058 DOI: 10.1055/a-1337-4462] [Reference Citation Analysis]
165 Jamshaid H, Zahid F, Din IU, Zeb A, Choi HG, Khan GM, Din FU. Diagnostic and Treatment Strategies for COVID-19. AAPS PharmSciTech 2020;21:222. [PMID: 32748244 DOI: 10.1208/s12249-020-01756-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
166 Daoud B, Cazejust J, Tavolaro S, Durand S, Pommier R, Hamrouni A, Bornet G. Could Spectral CT Have a Potential Benefit in Coronavirus Disease (COVID-19)? AJR Am J Roentgenol 2021;216:349-54. [PMID: 32822225 DOI: 10.2214/AJR.20.23546] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
167 Farhat Ullah M, Ali Y, Ramzan Khan M, Ullah Khan I, Yan B, Ijaz Khan M, Malik MY. A review of COVID-19: Treatment Strategies and CRISPR/Cas9 gene editing technology approaches to the coronavirus disease. Saudi J Biol Sci 2021. [PMID: 34658640 DOI: 10.1016/j.sjbs.2021.10.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
168 Ghidoli M, Colombo F, Sangiorgio S, Landoni M, Giupponi L, Nielsen E, Pilu R. Food Containing Bioactive Flavonoids and Other Phenolic or Sulfur Phytochemicals With Antiviral Effect: Can We Design a Promising Diet Against COVID-19? Front Nutr 2021;8:661331. [PMID: 34222300 DOI: 10.3389/fnut.2021.661331] [Reference Citation Analysis]
169 Torrinhas RS, Calder PC, Lemos GO, Waitzberg DL. Parenteral fish oil: An adjuvant pharmacotherapy for coronavirus disease 2019? Nutrition 2021;81:110900. [PMID: 32738510 DOI: 10.1016/j.nut.2020.110900] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
170 Diani E, Piccaluga PP, Lotti V, Di Clemente A, Ligozzi M, De Nardo P, Lambertenghi L, Pizzolo F, Friso S, Lo Cascio G, Vianello A, Marchi G, Concia E, Gibellini D. Assessment of SARS-CoV-2 IgG and IgM antibody detection with a lateral flow immunoassay test. Heliyon 2021;7:e08192. [PMID: 34693063 DOI: 10.1016/j.heliyon.2021.e08192] [Reference Citation Analysis]
171 Al-Waleedi AA, Naiene JD, Thabet AAK, Dandarawe A, Salem H, Mohammed N, Al Noban M, Bin-Azoon NS, Shawqi A, Rajamanar M, Al-Jariri R, Al Hyubaishi M, Khanbari L, Thabit N, Obaid B, Baaees M, Assaf D, Senga M, Bashir IM, Mahmoud N, Cosico R, Smith P, Musani A. The first 2 months of the SARS-CoV-2 epidemic in Yemen: Analysis of the surveillance data. PLoS One 2020;15:e0241260. [PMID: 33119720 DOI: 10.1371/journal.pone.0241260] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
172 Kohmer N, Rabenau HF, Hoehl S, Kortenbusch M, Ciesek S, Berger A. Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs). J Virol Methods 2021;291:114102. [PMID: 33607117 DOI: 10.1016/j.jviromet.2021.114102] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
173 Laneri S, Brancaccio M, Mennitti C, De Biasi MG, Pero ME, Pisanelli G, Scudiero O, Pero R. Antimicrobial Peptides and Physical Activity: A Great Hope against COVID 19. Microorganisms 2021;9:1415. [PMID: 34209064 DOI: 10.3390/microorganisms9071415] [Reference Citation Analysis]
174 Rana PS, Sharma N. The modeling and analysis of the COVID-19 pandemic with vaccination and treatment control: a case study of Maharashtra, Delhi, Uttarakhand, Sikkim, and Russia in the light of pharmaceutical and non-pharmaceutical approaches. Eur Phys J Spec Top 2022;:1-20. [PMID: 35432778 DOI: 10.1140/epjs/s11734-022-00534-5] [Reference Citation Analysis]
175 Loey M, Manogaran G, Khalifa NEM. A deep transfer learning model with classical data augmentation and CGAN to detect COVID-19 from chest CT radiography digital images. Neural Comput Appl 2020;:1-13. [PMID: 33132536 DOI: 10.1007/s00521-020-05437-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
176 Faried A, Dian S, Halim D, Hermanto Y, Pratama DMA, Arifin MZ. The neurological significance of COVID-19: Lesson learn from the pandemic. Interdiscip Neurosurg 2020;22:100809. [PMID: 33520665 DOI: 10.1016/j.inat.2020.100809] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
177 Saini P. COVID-19 pandemic: potential phase III vaccines in development. TABCJ. [DOI: 10.52679/tabcj.2020.0004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
178 Ganesh B, Rajakumar T, Malathi M, Manikandan N, Nagaraj J, Santhakumar A, Elangovan A, Malik YS. Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives. Clin Epidemiol Glob Health 2021;10:100694. [PMID: 33462564 DOI: 10.1016/j.cegh.2020.100694] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
179 Pérez-Fuentes MDC, Molero Jurado MDM, Oropesa Ruiz NF, Martos Martínez Á, Simón Márquez MDM, Herrera-Peco I, Gázquez Linares JJ. Questionnaire on Perception of Threat from COVID-19. J Clin Med 2020;9:E1196. [PMID: 32331246 DOI: 10.3390/jcm9041196] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
180 Zyoud SH. The Arab region's contribution to global COVID-19 research: Bibliometric and visualization analysis. Global Health 2021;17:31. [PMID: 33766073 DOI: 10.1186/s12992-021-00690-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 18.0] [Reference Citation Analysis]
181 Kim M, Linstadt RTH, Ahn Ando K, Ahn J. Gemini-Mediated Self-Disinfecting Surfaces to Address the Contact Transmission of Infectious Diseases. Langmuir 2022. [PMID: 35108488 DOI: 10.1021/acs.langmuir.1c03401] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
182 Selvakumar K, Lokesh S. The prediction of the lifetime of the new coronavirus in the USA using mathematical models. Soft comput 2021;:1-20. [PMID: 33716562 DOI: 10.1007/s00500-021-05643-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
183 Jacobs ED, Okeke MI. A critical evaluation of Nigeria’s response to the first wave of COVID-19. Bull Natl Res Cent 2022;46. [DOI: 10.1186/s42269-022-00729-9] [Reference Citation Analysis]
184 Stone NE, Jaramillo SA, Jones AN, Vazquez AJ, Martz M, Versluis LM, Raniere MO, Nunnally HE, Zarn KE, Nottingham R, Ng KR, Sahl JW, Wagner DM, Knudsen S, Settles EW, Keim P, French CT. Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses In Vitro. mBio 2021;12:e03495-20. [PMID: 33468703 DOI: 10.1128/mBio.03495-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
185 Hassan MM, Kalam MA, Shano S, Nayem MRK, Rahman MK, Khan SA, Islam A. Assessment of Epidemiological Determinants of COVID-19 Pandemic Related to Social and Economic Factors Globally. JRFM 2020;13:194. [DOI: 10.3390/jrfm13090194] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 6.5] [Reference Citation Analysis]
186 Azad GK, Khan PK. Variations in Orf3a protein of SARS-CoV-2 alter its structure and function. Biochem Biophys Rep 2021;26:100933. [PMID: 33527091 DOI: 10.1016/j.bbrep.2021.100933] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
187 Thione A, Sánchez-García A, Pérez-García A, García-Vilariño E, Salmerón-González E, Balaguer-Cambra J. A Protocol for Performing Reconstructive Microsurgery on Patients With COVID-19. Plast Surg Nurs 2021;41:36-9. [PMID: 33626561 DOI: 10.1097/PSN.0000000000000352] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
188 AlGhamdi NA, Alsuwat HS, Borgio JF, AbdulAzeez S. Emerging of composition variations of SARS-CoV-2 spike protein and human ACE2 contribute to the level of infection: in silico approaches. J Biomol Struct Dyn 2020;:1-12. [PMID: 33138699 DOI: 10.1080/07391102.2020.1841032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
189 Verma HK. Radiological and clinical spectrum of COVID-19: A major concern for public health. World J Radiol 2021; 13(3): 53-63 [PMID: 33815683 DOI: 10.4329/wjr.v13.i3.53] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
190 Vaidya NA, Vyas R. Computational Studies of Hydroxychloroquine and Chloroquine Metabolites as Possible Candidates for Coronavirus (COVID-19) Treatment. Front Pharmacol 2020;11:569665. [PMID: 33364944 DOI: 10.3389/fphar.2020.569665] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
191 Janik E, Ceremuga M, Niemcewicz M, Bijak M. Dangerous Pathogens as a Potential Problem for Public Health. Medicina (Kaunas) 2020;56:E591. [PMID: 33172013 DOI: 10.3390/medicina56110591] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
192 Khan M, Adil SF, Alkhathlan HZ, Tahir MN, Saif S, Khan M, Khan ST. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far. Molecules 2020;26:E39. [PMID: 33374759 DOI: 10.3390/molecules26010039] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
193 Malik YS, Obli Rajendran V, Ma I, Pande T, Ravichandran K, Jaganathasamy N, Ganesh B, Santhakumar A, Tazerji SS, Rahman MT, Safdar M, Dubal ZB, Dhama K. Responses to COVID-19 in South Asian Association for Regional Cooperation (SAARC) countries in 2020, a data analysis during a world of crises. Chaos Solitons Fractals 2021;152:111311. [PMID: 34376927 DOI: 10.1016/j.chaos.2021.111311] [Reference Citation Analysis]
194 Kumar G, Kumar D, Singh NP. Therapeutic Approach against 2019-nCoV by Inhibition of ACE-2 Receptor. Drug Res (Stuttg) 2021;71:213-8. [PMID: 33184809 DOI: 10.1055/a-1275-0228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
195 Ruiz-Roso MB, de Carvalho Padilha P, Mantilla-Escalante DC, Ulloa N, Brun P, Acevedo-Correa D, Arantes Ferreira Peres W, Martorell M, Aires MT, de Oliveira Cardoso L, Carrasco-Marín F, Paternina-Sierra K, Rodriguez-Meza JE, Montero PM, Bernabè G, Pauletto A, Taci X, Visioli F, Dávalos A. Covid-19 Confinement and Changes of Adolescent's Dietary Trends in Italy, Spain, Chile, Colombia and Brazil. Nutrients 2020;12:E1807. [PMID: 32560550 DOI: 10.3390/nu12061807] [Cited by in Crossref: 105] [Cited by in F6Publishing: 74] [Article Influence: 52.5] [Reference Citation Analysis]
196 Barber E, Kovo M, Leytes S, Sagiv R, Weiner E, Schwartz O, Mashavi M, Holtzman K, Bar J, Engel A, Ginath S. Evaluation of SARS-CoV-2 in the Vaginal Secretions of Women with COVID-19: A Prospective Study. J Clin Med 2021;10:2735. [PMID: 34205751 DOI: 10.3390/jcm10122735] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
197 Sabbih GO, Korsah MA, Jeevanandam J, Danquah MK. Biophysical analysis of SARS-CoV-2 transmission and theranostic development via N protein computational characterization. Biotechnol Prog 2021;37:e3096. [PMID: 33118327 DOI: 10.1002/btpr.3096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
198 Yamada H, Okamoto M, Nagasaki Y, Yoshio S, Nouno T, Yano C, Tanaka T, Watanabe F, Shibata N, Arimizu Y, Fukamachi Y, Zaizen Y, Hamada N, Kawaguchi A, Hoshino T, Morita S. Analysis of Early Biomarkers Associated with the Development of Critical Respiratory Failure in Coronavirus Disease 2019 (COVID-19). Diagnostics 2022;12:339. [DOI: 10.3390/diagnostics12020339] [Reference Citation Analysis]
199 Rad HS, Röhl J, Stylianou N, Allenby MC, Bazaz SR, Warkiani ME, Guimaraes FSF, Clifton VL, Kulasinghe A. The Effects of COVID-19 on the Placenta During Pregnancy. Front Immunol 2021;12:743022. [PMID: 34603330 DOI: 10.3389/fimmu.2021.743022] [Reference Citation Analysis]
200 Aquino-Martinez R, Hernández-Vigueras S. Severe COVID-19 Lung Infection in Older People and Periodontitis. J Clin Med 2021;10:E279. [PMID: 33466585 DOI: 10.3390/jcm10020279] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
201 Tripathi MK, Singh P, Sharma S, Singh TP, Ethayathulla AS, Kaur P. Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor. J Biomol Struct Dyn 2021;39:5668-81. [PMID: 32643552 DOI: 10.1080/07391102.2020.1790425] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
202 Ibrahim TM, Ismail MI, Bauer MR, Bekhit AA, Boeckler FM. Supporting SARS-CoV-2 Papain-Like Protease Drug Discovery: In silico Methods and Benchmarking. Front Chem 2020;8:592289. [PMID: 33251185 DOI: 10.3389/fchem.2020.592289] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
203 Yang D. Application of Nanotechnology in the COVID-19 Pandemic. Int J Nanomedicine 2021;16:623-49. [PMID: 33531805 DOI: 10.2147/IJN.S296383] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
204 Jose S, Gupta M, Sharma U, Quintero-Saumeth J, Dwivedi M. Potential of phytocompounds from Brassica oleracea targeting S2-domain of SARS-CoV-2 spike glycoproteins: Structural and molecular insights. J Mol Struct 2022;1254:132369. [PMID: 35034979 DOI: 10.1016/j.molstruc.2022.132369] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
205 Kabir ER, Mustafa N, Nausheen N, Sharif Siam MK, Syed EU. Exploring existing drugs: proposing potential compounds in the treatment of COVID-19. Heliyon 2021;7:e06284. [PMID: 33655082 DOI: 10.1016/j.heliyon.2021.e06284] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
206 Muralidar S, Ambi SV, Sekaran S, Krishnan UM. The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2. Biochimie 2020;179:85-100. [PMID: 32971147 DOI: 10.1016/j.biochi.2020.09.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
207 Mulaw Belete T. An Up-to-Date Overview of Therapeutic Agents for the Treatment of COVID-19 Disease. Clin Pharmacol 2020;12:203-12. [PMID: 33363416 DOI: 10.2147/CPAA.S284809] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
208 Abuo-rahma GEA, Mohamed MFA, Ibrahim TS, Shoman ME, Samir E, Abd El-baky RM. Potential repurposed SARS-CoV-2 (COVID-19) infection drugs. RSC Adv 2020;10:26895-916. [DOI: 10.1039/d0ra05821a] [Cited by in Crossref: 18] [Article Influence: 9.0] [Reference Citation Analysis]
209 Osman M, Klopfenstein T, Belfeki N, Gendrin V, Zayet S. A Comparative Systematic Review of COVID-19 and Influenza. Viruses 2021;13:452. [PMID: 33802155 DOI: 10.3390/v13030452] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
210 Anwar MM, Sah R, Shrestha S, Ozaki A, Roy N, Fathah Z, Rodriguez-Morales AJ. Disengaging the COVID-19 Clutch as a Discerning Eye Over the Inflammatory Circuit During SARS-CoV-2 Infection. Inflammation 2022. [PMID: 35639261 DOI: 10.1007/s10753-022-01674-5] [Reference Citation Analysis]
211 Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol. 2020;215:108427. [PMID: 32325252 DOI: 10.1016/j.clim.2020.108427] [Cited by in Crossref: 475] [Cited by in F6Publishing: 397] [Article Influence: 237.5] [Reference Citation Analysis]
212 Skalski SB, Konaszewski K, Büssing A, Surzykiewicz J. Resilience and Mental Well-Being During the COVID-19 Pandemic: Serial Mediation by Persistent Thinking and Anxiety About Coronavirus. Front Psychiatry 2022;12:810274. [DOI: 10.3389/fpsyt.2021.810274] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
213 Wong KK, Lee SWH, Kua KP. N-Acetylcysteine as Adjuvant Therapy for COVID-19 - A Perspective on the Current State of the Evidence. J Inflamm Res 2021;14:2993-3013. [PMID: 34262324 DOI: 10.2147/JIR.S306849] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
214 Chechetkin VR, Lobzin VV. Evolving ribonucleocapsid assembly/packaging signals in the genomes of the human and animal coronaviruses: targeting, transmission and evolution. J Biomol Struct Dyn 2021;:1-25. [PMID: 34338591 DOI: 10.1080/07391102.2021.1958061] [Reference Citation Analysis]
215 Franzo G. SARS-CoV-2 and other human coronavirus show genome patterns previously associated to reduced viral recognition and altered immune response. Sci Rep 2021;11:10696. [PMID: 34021237 DOI: 10.1038/s41598-021-90278-4] [Reference Citation Analysis]
216 Srivastava A, Gupta RC, Doss RB, Lall R. Trace Minerals, Vitamins and Nutraceuticals in Prevention and Treatment of COVID-19. J Diet Suppl 2021;:1-35. [PMID: 33682615 DOI: 10.1080/19390211.2021.1890662] [Reference Citation Analysis]
217 Kirar M, Singh H, Sehrawat N. Virtual screening and molecular dynamics simulation study of plant protease inhibitors against SARS-CoV-2 envelope protein. Informatics in Medicine Unlocked 2022. [DOI: 10.1016/j.imu.2022.100909] [Reference Citation Analysis]
218 Astuti I, Ysrafil. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab Syndr 2020;14:407-12. [PMID: 32335367 DOI: 10.1016/j.dsx.2020.04.020] [Cited by in Crossref: 564] [Cited by in F6Publishing: 440] [Article Influence: 282.0] [Reference Citation Analysis]
219 Madi N, Al-Awadhi E, Al-Assaf F. Dynamic profile of SARS-CoV-2 infection among hospitalized patients in Kuwait: a descriptive study. BMC Infect Dis 2021;21:758. [PMID: 34353284 DOI: 10.1186/s12879-021-06504-x] [Reference Citation Analysis]
220 Słomka A, Kowalewski M, Żekanowska E. Hemostasis in Coronavirus Disease 2019-Lesson from Viscoelastic Methods: A Systematic Review. Thromb Haemost 2021;121:1181-92. [PMID: 33401332 DOI: 10.1055/a-1346-3178] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
221 Bagasra O, Pandey P, Sanamandra JR, Houston JM, McLean E, Albrecht H. Infectivity of Human Olfactory Neurons to SARS-CoV-2: A Link to Anosmia. Oman Med J 2021;36:e307. [PMID: 34733553 DOI: 10.5001/omj.2021.128] [Reference Citation Analysis]
222 Li W, Li M, Ou G. COVID-19, cilia, and smell. FEBS J 2020;287:3672-6. [PMID: 32692465 DOI: 10.1111/febs.15491] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
223 Combadière B. [Adaptive immunity against SARS-CoV-2]. Med Sci (Paris) 2020;36:908-13. [PMID: 32960167 DOI: 10.1051/medsci/2020168] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
224 Witika BA, Makoni PA, Mweetwa LL, Ntemi PV, Chikukwa MTR, Matafwali SK, Mwila C, Mudenda S, Katandula J, Walker RB. Nano-Biomimetic Drug Delivery Vehicles: Potential Approaches for COVID-19 Treatment. Molecules 2020;25:E5952. [PMID: 33339110 DOI: 10.3390/molecules25245952] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
225 Sharmeen S, Elghawy A, Zarlasht F, Yao Q. COVID-19 in rheumatic disease patients on immunosuppressive agents. Semin Arthritis Rheum 2020;50:680-6. [PMID: 32512263 DOI: 10.1016/j.semarthrit.2020.05.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
226 Asano T, Chelvanambi S, Decano JL, Whelan MC, Aikawa E, Aikawa M. In silico Drug Screening Approach Using L1000-Based Connectivity Map and Its Application to COVID-19. Front Cardiovasc Med 2022;9:842641. [DOI: 10.3389/fcvm.2022.842641] [Reference Citation Analysis]
227 Mahalingam S, Peter J, Xu Z, Bordoloi D, Ho M, Kalyanaraman VS, Srinivasan A, Muthumani K. Landscape of humoral immune responses against SARS-CoV-2 in patients with COVID-19 disease and the value of antibody testing. Heliyon 2021;7:e06836. [PMID: 33898857 DOI: 10.1016/j.heliyon.2021.e06836] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
228 Khalifa NEM, Smarandache F, Manogaran G, Loey M. A Study of the Neutrosophic Set Significance on Deep Transfer Learning Models: an Experimental Case on a Limited COVID-19 Chest X-ray Dataset. Cognit Comput 2021;:1-10. [PMID: 33425043 DOI: 10.1007/s12559-020-09802-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
229 Shahin MAH, Hussien RM. Risk perception regarding the COVID-19 outbreak among the general population: a comparative Middle East survey. Middle East Curr Psychiatry 2020;27. [DOI: 10.1186/s43045-020-00080-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
230 Samaha AA, Mouawia H, Fawaz M, Hassan H, Salami A, Bazzal AA, Saab HB, Al-Wakeel M, Alsaabi A, Chouman M, Moussawi MA, Ayoub H, Raad A, Hajjeh O, Eid AH, Raad H. Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon. Viruses 2021;13:989. [PMID: 34073401 DOI: 10.3390/v13060989] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
231 Cerbu B, Pantea S, Bratosin F, Vidican I, Turaiche M, Frent S, Borsi E, Marincu I. Liver Impairment and Hematological Changes in Patients with Chronic Hepatitis C and COVID-19: A Retrospective Study after One Year of Pandemic. Medicina (Kaunas) 2021;57:597. [PMID: 34200570 DOI: 10.3390/medicina57060597] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
232 Belete TM. A review on Promising vaccine development progress for COVID-19 disease. Vacunas (English Edition) 2020;21:121-8. [DOI: 10.1016/j.vacune.2020.10.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
233 Konwarh R. Can CRISPR/Cas Technology Be a Felicitous Stratagem Against the COVID-19 Fiasco? Prospects and Hitches. Front Mol Biosci 2020;7:557377. [PMID: 33134311 DOI: 10.3389/fmolb.2020.557377] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
234 Ram TS, Munikumar M, Raju VN, Devaraj P, Boiroju NK, Hemalatha R, Prasad PVV, Gundeti M, Sisodia BS, Pawar S, Prasad GP, Chincholikar M, Goel S, Mangal A, Gaidhani S, Srikanth N, Dhiman KS. In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease. J Ayurveda Integr Med 2021. [PMID: 33654345 DOI: 10.1016/j.jaim.2021.02.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 16.0] [Reference Citation Analysis]
235 Kumari M, Kumar A. Environmental and human health risk assessment of mixture of Covid-19 treating pharmaceutical drugs in environmental waters. Sci Total Environ 2021;812:152485. [PMID: 34942257 DOI: 10.1016/j.scitotenv.2021.152485] [Reference Citation Analysis]
236 Khan A, Khan T, Ali S, Aftab S, Wang Y, Qiankun W, Khan M, Suleman M, Ali S, Heng W, Ali SS, Wei DQ, Mohammad A. SARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccines. Biomed Pharmacother 2021;143:112176. [PMID: 34562770 DOI: 10.1016/j.biopha.2021.112176] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
237 Dodig S, Čepelak I, Čepelak Dodig D, Laškaj R. SARS-CoV-2 - a new challenge for laboratory medicine. Biochem Med (Zagreb) 2020;30:030503. [PMID: 32774121 DOI: 10.11613/BM.2020.030503] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
238 Lucaciu O, Aghiorghiesei O, Petrescu NB, Mirica IC, Benea HRC, Apostu D. In quest of a new therapeutic approach in COVID-19: the endocannabinoid system. Drug Metab Rev 2021;:1-13. [PMID: 33683968 DOI: 10.1080/03602532.2021.1895204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
239 Sonkar C, Kashyap D, Varshney N, Baral B, Jha HC. Impact of Gastrointestinal Symptoms in COVID-19: a Molecular Approach. SN Compr Clin Med 2020;:1-12. [PMID: 33169110 DOI: 10.1007/s42399-020-00619-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
240 Kolozsvári LR, Bérczes T, Hajdu A, Gesztelyi R, Tiba A, Varga I, Al-Tammemi AB, Szőllősi GJ, Harsányi S, Garbóczy S, Zsuga J. Predicting the epidemic curve of the coronavirus (SARS-CoV-2) disease (COVID-19) using artificial intelligence: An application on the first and second waves. Inform Med Unlocked 2021;25:100691. [PMID: 34395821 DOI: 10.1016/j.imu.2021.100691] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
241 Lozano-Sepulveda SA, Galan-Huerta K, Martínez-Acuña N, Arellanos-Soto D, Rivas-Estilla AM. SARS-CoV-2 another kind of liver aggressor, how does it do that? Ann Hepatol 2020;19:592-6. [PMID: 32858226 DOI: 10.1016/j.aohep.2020.08.062] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
242 Gaborieau L, Delestrain C, Bensaid P, Vizeneux A, Blanc P, Garraffo A, Georget E, Chalvon A, Garrec N, Laoudi Y, Varon E, Rouget S, Pupin A, Abdel Aal K, Toulorge D, Ducrocq S, Barrey C, Pantalone L, Robert B, Joly-Sanchez L, Thach C, Masserot-Lureau C, Chahine J, Garcia-Roudaut VR, Rozental J, Nathanson S, Khaled M, Mandelcwajg A, Demayer N, Muller S, Mazerghane M, Epaud R, Pellegrino B, Madhi F. Epidemiology and Clinical Presentation of Children Hospitalized with SARS-CoV-2 Infection in Suburbs of Paris. J Clin Med 2020;9:E2227. [PMID: 32674306 DOI: 10.3390/jcm9072227] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
243 Olwenyi OA, Dyavar SR, Acharya A, Podany AT, Fletcher CV, Ng CL, Reid SP, Byrareddy SN. Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19). J Mol Med (Berl) 2020;98:1369-83. [PMID: 32808094 DOI: 10.1007/s00109-020-01961-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
244 Praharaj MR, Garg P, Kesarwani V, Topno NA, Khan RIN, Sharma S, Panigrahi M, Mishra BP, Mishra B, Kumar GS, Gandham RK, Singh RK, Majumdar S, Mohapatra T. SARS-CoV-2 Spike Glycoprotein and ACE2 Interaction Reveals Modulation of Viral Entry in Wild and Domestic Animals. Front Med 2022;8:775572. [DOI: 10.3389/fmed.2021.775572] [Reference Citation Analysis]
245 Sharma I, Kumari P, Sharma A, Saha SC. SARS-CoV-2 and the reproductive system: known and the unknown..!! Middle East Fertil Soc J 2021;26:1. [PMID: 33437145 DOI: 10.1186/s43043-020-00046-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
246 Hysenaj L, Little S, Kulhanek K, Gbenedio OM, Rodriguez L, Shen A, Lone JC, Lupin-Jimenez LC, Bonser LR, Serwas NK, Bahl K, Mick E, Li JZ, Ding VW, Matsumoto S, Maishan M, Simoneau C, Fragiadakis G, Jablons DM, Langelier CR, Matthay M, Ott M, Krummel M, Combes AJ, Sil A, Erle DJ, Kratz JR, Roose JP. SARS-CoV-2 infection studies in lung organoids identify TSPAN8 as novel mediator. bioRxiv 2021:2021. [PMID: 34100012 DOI: 10.1101/2021.06.01.446640] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
247 Landeras-Bueno S, Wasserman H, Oliveira G, VanAernum ZL, Busch F, Salie ZL, Wysocki VH, Andersen K, Saphire EO. Cellular mRNA triggers structural transformation of Ebola virus matrix protein VP40 to its essential regulatory form. Cell Rep 2021;35:108986. [PMID: 33852858 DOI: 10.1016/j.celrep.2021.108986] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
248 Hakim A, Hasan MM, Hasan M, Lokman SM, Azim KF, Raihan T, Chowdhury PA, Azad AK. Major Insights in Dynamics of Host Response to SARS-CoV-2: Impacts and Challenges. Front Microbiol 2021;12:637554. [PMID: 34512561 DOI: 10.3389/fmicb.2021.637554] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
249 Naz A, Billah M. COVID-19 and Coronary Heart Disease. Encyclopedia 2021;1:340-9. [DOI: 10.3390/encyclopedia1020028] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
250 Asadi S, Nilashi M, Abumalloh RA, Samad S, Ahani A, Ghabban F, Yusuf SYM, Supriyanto E. Evaluation of Factors to Respond to the COVID-19 Pandemic Using DEMATEL and Fuzzy Rule-Based Techniques. Int J Fuzzy Syst 2022;24:27-43. [DOI: 10.1007/s40815-021-01119-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
251 [DOI: 10.1101/2020.05.08.085506] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
252 Harritshøj LH, Gybel-Brask M, Afzal S, Kamstrup PR, Jørgensen CS, Thomsen MK, Hilsted L, Friis-Hansen L, Szecsi PB, Pedersen L, Nielsen L, Hansen CB, Garred P, Korsholm TL, Mikkelsen S, Nielsen KO, Møller BK, Hansen AT, Iversen KK, Nielsen PB, Hasselbalch RB, Fogh K, Norsk JB, Kristensen JH, Schønning K, Kirkby NS, Nielsen ACY, Landsy LH, Loftager M, Holm DK, Nilsson AC, Sækmose SG, Grum-Schwensen B, Aagaard B, Jensen TG, Nielsen DM, Ullum H, Dessau RB. Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories. J Clin Microbiol 2021;59:e02596-20. [PMID: 33574119 DOI: 10.1128/JCM.02596-20] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 19.0] [Reference Citation Analysis]
253 Skalski S, Uram P, Dobrakowski P, Kwiatkowska A. The link between ego-resiliency, social support, SARS-CoV-2 anxiety and trauma effects. Polish adaptation of the Coronavirus Anxiety Scale. Pers Individ Dif 2021;171:110540. [PMID: 33223590 DOI: 10.1016/j.paid.2020.110540] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
254 Jakhmola S, Indari O, Baral B, Kashyap D, Varshney N, Das A, Chatterjee S, Jha HC. Comorbidity Assessment Is Essential During COVID-19 Treatment. Front Physiol 2020;11:984. [PMID: 32903640 DOI: 10.3389/fphys.2020.00984] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
255 Maghsood F, Hassani D, Salimi V, Kardar GA, Khoshnoodi J, Ghaderi A, Raeeskarami SR, Rostamian A, Seyyedsalehi MS, Ahmadi Fesharaki R, Jeddi-Tehrani M, Zarnani AH, Amiri MM, Shokri F. Differential Antibody Response to SARS-CoV-2 Antigens in Recovered and Deceased Iranian COVID-19 Patients. Viral Immunol 2021. [PMID: 34534012 DOI: 10.1089/vim.2021.0061] [Reference Citation Analysis]
256 Sahoo BM, Ravi Kumar BVV, Sruti J, Mahapatra MK, Banik BK, Borah P. Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection. Front Mol Biosci 2021;8:628144. [PMID: 33718434 DOI: 10.3389/fmolb.2021.628144] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
257 Hudák A, Letoha A, Szilák L, Letoha T. Contribution of Syndecans to the Cellular Entry of SARS-CoV-2. Int J Mol Sci 2021;22:5336. [PMID: 34069441 DOI: 10.3390/ijms22105336] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
258 Berber B, Doluca O. A comprehensive drug repurposing study for COVID19 treatment: novel putative dihydroorotate dehydrogenase inhibitors show association to serotonin-dopamine receptors. Brief Bioinform 2021;22:1023-37. [PMID: 33406218 DOI: 10.1093/bib/bbaa379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
259 Mohammed El Tabaa M, Mohammed El Tabaa M. Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost. Biochem Pharmacol 2020;178:114057. [PMID: 32470547 DOI: 10.1016/j.bcp.2020.114057] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
260 Sahu B, Das PK, Kabat MR, Kumar R. Prevention of Covid-19 affected patient using multi robot cooperation and Q-learning approach: a solution. Qual Quant 2021;:1-29. [PMID: 33972809 DOI: 10.1007/s11135-021-01155-1] [Reference Citation Analysis]
261 Ahmad A, Raish M, Alkharfy KM. The potential role of thymoquinone in preventing the cardiovascular complications of COVID-19. Vascul Pharmacol 2021;:106899. [PMID: 34311073 DOI: 10.1016/j.vph.2021.106899] [Reference Citation Analysis]
262 Ogar CO, Okoroiwu HU, Obeagu EI, Etura JE, Abunimye DA. Assessment of blood supply and usage pre- and during COVID-19 pandemic: A lesson from non-voluntary donation. Transfus Clin Biol 2021;28:68-72. [PMID: 33080420 DOI: 10.1016/j.tracli.2020.10.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
263 Santos JC, Ribeiro ML, Gambero A. The Impact of Polyphenols-Based Diet on the Inflammatory Profile in COVID-19 Elderly and Obese Patients. Front Physiol 2020;11:612268. [PMID: 33584335 DOI: 10.3389/fphys.2020.612268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
264 El Hassab MA, Ibrahim TM, Shoun AA, Al-rashood ST, Alkahtani HM, Alharbi A, Eskandrani RO, Eldehna WM. In silico identification of potential SARS COV-2 2′- O -methyltransferase inhibitor: fragment-based screening approach and MM-PBSA calculations. RSC Adv 2021;11:16026-33. [DOI: 10.1039/d1ra01809d] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
265 Başcı S, Ata N, Altuntaş F, Yiğenoğlu TN, Dal MS, Korkmaz S, Namdaroğlu S, Baştürk A, Hacıbekiroğlu T, Doğu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Çağlayan M, Ayvalı MO, Çelik O, Ülgü MM, Birinci Ş; Turkish Ministry of Health, Hematology Scientific Working Group. Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors. J Oncol Pharm Pract 2020;26:1676-82. [PMID: 32854573 DOI: 10.1177/1078155220953198] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
266 Bačenková D, Trebuňová M, Špakovská T, Schnitzer M, Bednarčíková L, Živčák J. Comparison of Selected Characteristics of SARS-CoV-2, SARS-CoV, and HCoV-NL63. Applied Sciences 2021;11:1497. [DOI: 10.3390/app11041497] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
267 Marengoni A, Zucchelli A, Vetrano DL, Armellini A, Botteri E, Nicosia F, Romanelli G, Beindorf EA, Giansiracusa P, Garrafa E, Ferrucci L, Fratiglioni L, Bernabei R, Onder G. Beyond Chronological Age: Frailty and Multimorbidity Predict In-Hospital Mortality in Patients With Coronavirus Disease 2019. J Gerontol A Biol Sci Med Sci 2021;76:e38-45. [PMID: 33216846 DOI: 10.1093/gerona/glaa291] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 19.0] [Reference Citation Analysis]
268 Walsh KA, Spillane S, Comber L, Cardwell K, Harrington P, Connell J, Teljeur C, Broderick N, de Gascun CF, Smith SM, Ryan M, O'Neill M. The duration of infectiousness of individuals infected with SARS-CoV-2. J Infect 2020;81:847-56. [PMID: 33049331 DOI: 10.1016/j.jinf.2020.10.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 16.5] [Reference Citation Analysis]
269 Freire M, Andrade A, Sopeña B, Lopez-Rodriguez M, Varela P, Cacabelos P, Esteban H, González-Quintela A. Guillain Barré syndrome associated with COVID-19- lessons learned about its pathogenesis during the first year of the pandemic, a systematic review. Autoimmun Rev 2021;20:102875. [PMID: 34119673 DOI: 10.1016/j.autrev.2021.102875] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
270 Siriwattananon K, Manopwisedjaroen S, Kanjanasirirat P, Budi Purwono P, Rattanapisit K, Shanmugaraj B, Smith DR, Borwornpinyo S, Thitithanyanont A, Phoolcharoen W. Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2. Front Plant Sci 2020;11:604663. [PMID: 33584747 DOI: 10.3389/fpls.2020.604663] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
271 Kunnumakkara AB, Rana V, Parama D, Banik K, Girisa S, Henamayee S, Thakur KK, Dutta U, Garodia P, Gupta SC, Aggarwal BB. COVID-19, cytokines, inflammation, and spices: How are they related? Life Sci 2021;:119201. [PMID: 33607159 DOI: 10.1016/j.lfs.2021.119201] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
272 Tammam SN, El Safy S, Ramadan S, Arjune S, Krakor E, Mathur S. Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2. J Control Release 2021;337:258-84. [PMID: 34293319 DOI: 10.1016/j.jconrel.2021.07.028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
273 Ayisi-Boateng NK, Owusu M, Tawiah P, Ampah BA, Sylverken AA, Wusu-Ansah OK, Sarfo FS, Phillips RO. Profile and outcomes of hospitalized patients with COVID-19 at a tertiary institution hospital in Ghana. Ghana Med J 2020;54:39-45. [PMID: 33976440 DOI: 10.4314/gmj.v54i4s.7] [Reference Citation Analysis]
274 Shestakova MV, Mokrysheva NG, Dedov II. Course and treatment of diabetes mellitus in the context of COVID-19. Diabetes mellitus 2020;23:132-9. [DOI: 10.14341/dm12418] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
275 Dadhwal R, Sharma M, Surani S. Restrictive Lung Disease in Patients With Subclinical Coronavirus Infection: Are We Bracing Ourselves for Devastating Sequelae? Cureus 2021;13:e12501. [PMID: 33564509 DOI: 10.7759/cureus.12501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
276 Wang CYT, Buckley C, Bletchly C, Harris P, Whiley D. Contamination of SARS-CoV-2 RT-PCR probes at the oligonucleotide manufacturer. Pathology 2020;52:814-6. [PMID: 32888705 DOI: 10.1016/j.pathol.2020.08.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
277 Herazo MS, Nani G, Zurita F, Nakase C, Zamora S, Herazo LCS, Betanzo-torres EA. A Review of the Presence of SARS-CoV-2 in Wastewater: Transmission Risks in Mexico. IJERPH 2022;19:8354. [DOI: 10.3390/ijerph19148354] [Reference Citation Analysis]
278 Giri R, Kumar A, Saini M, Sharma RK. Living with the virus: Infection and epidemiology of COVID-19 in hotspot area of India. J Public Aff 2021;:e2651. [PMID: 33786027 DOI: 10.1002/pa.2651] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
279 Saha T, Sinha S, Harfoot R, Quiñones-Mateu ME, Das SC. Manipulation of Spray-Drying Conditions to Develop an Inhalable Ivermectin Dry Powder. Pharmaceutics 2022;14:1432. [PMID: 35890327 DOI: 10.3390/pharmaceutics14071432] [Reference Citation Analysis]